In the early stage, the pharmacologic treatments for PD motor symptoms are primarily dopamine based, such as using levodopa preparations, dopamine agonists, and monoamine oxidase-B (MAO-B) inhibitors [3]. The gene discussed is MAOB; the disease is Parkinson disease.